Krystal Biotech, Inc. (KRYS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	3.2	0.0
Revenue growth					-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	6.4	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	-3.2	0.0
Gross margin						-100.0%
Selling, general and administrative [+]	77.7	40.4	15.1	6.5	4.2	1.6	0.4
General and administrative	77.7	40.4	15.1	6.5	4.2	1.6	0.4
Research and development	42.5	27.9	17.9	15.6	7.8		0.7
Other operating expenses	25.0
EBITDA [+]	-141.1	-65.5	-31.1	-21.0	-11.8	-4.7	-1.1
EBITDA growth	115.5%	110.3%	48.4%	78.3%	147.9%	316.2%
EBITDA margin						-148.0%
Depreciation and amortization	4.1	2.8	1.9	1.1	0.1	0.0	0.0
EBIT [+]	-145.2	-68.3	-33.0	-22.1	-11.9	-4.8	-1.1
EBIT growth	112.7%	106.9%	49.4%	85.3%	149.7%	317.5%
EBIT margin						-148.8%
Interest income, net [+]		-1.5		3.0	1.0
Interest expense		1.5
Interest income				3.0	1.0
Other income (expense), net [+]	5.2	0.2	0.8			-3.1	0.0
Litigation settlement	25.0
Pre-tax income	-140.0	-69.6	-32.2	-19.1	-10.9	-7.9	-1.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-140.0	-69.6	-32.2	-19.1	-10.9	-7.9	-1.2
Net margin						-246.9%

Basic EPS [+]	($5.49)	($3.13)	($1.71)	($1.20)	($0.97)	($1.48)	($1.31)
Growth	75.2%	83.1%	42.6%	23.5%	-34.3%	12.9%
Diluted EPS [+]	($5.49)	($3.13)	($1.71)	($1.20)	($0.97)	($1.48)	($1.31)
Growth	75.2%	83.1%	42.6%	23.5%	-34.3%	12.9%

Shares outstanding (basic) [+]	25.5	22.2	18.8	15.9	11.2	5.4	0.9
Growth	14.8%	18.1%	18.2%	41.9%	109.4%	509.8%
Shares outstanding (diluted) [+]	25.5	22.2	18.8	15.9	11.2	5.4	0.9
Growth	14.8%	18.1%	18.2%	41.9%	109.4%	509.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.